Accessibility statement

Cost-effectiveness modelling of the liver disease pathway

Thursday 14 July 2016, 12.30PM to 1.30pm

Speaker(s): David Wonderling and Lefteris Floros, Royal College of Physicians, London

Abstract: The methods and results of a set of cost-utility analyses conducted for the NICE Cirrhosis and Non-Alcoholic Fatty Liver Disease (NAFLD) guidelines, which are about to go out for stakeholder consultation. These Markov models cover various diagnostic, and surveillance questions, including who should be tested, with which test and how frequently.
 
Cohorts included NAFLD, alcoholic liver disease, hepatitis B and hepatitis C. This presentation will focus on people with or at risk of NAFLD. The discussion will touch upon:
  • The complexity of disease pathway modelling
  • Interaction between patient choice and the  results of cost-effectiveness analysis
  • Incorporation of multiple NICE Single Technology Appraisals in to a clinical guideline model

Location: Alcuin A Block A019/020

Who to contact

For more information on these seminars, contact:
Alfredo Palacios
alfredo.palacios@york.ac.uk
Shainur Premji
shainur.premji@york.ac.uk

If you are not a member of University of York staff and are interested in attending a seminar, please contact
alfredo.palacios@york.ac.uk 
or
shainur.premji@york.ac.uk 
so that we can ensure we have sufficient space

Economic evaluation seminar dates

  • Thursday 8 December
    Ana Duarte, University of York